Management of adverse events related to first-generation tyrosine receptor kinase inhibitors in adults: a narrative review.
Christine MartineauMaria-Kim TurcotteNoémie OtisFrédéric ProvostLudovic ThemensMarie-Pascale GuayNathalie LetarteJean-Philippe AdamPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2022)
With the estimated growth of gene sequencing in the coming years, it is foreseeable that TRKi will take a larger position in the oncologic therapeutic arsenal. Therefore, adequate management of AEs associated with TRKi in adults should be a prime focus.